545 related articles for article (PubMed ID: 20686126)
1. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
Zou T; Caton AJ; Koretzky GA; Kambayashi T
J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126
[TBL] [Abstract][Full Text] [Related]
2. Gap junctions at the dendritic cell-T cell interface are key elements for antigen-dependent T cell activation.
Elgueta R; Tobar JA; Shoji KF; De Calisto J; Kalergis AM; Bono MR; Rosemblatt M; Sáez JC
J Immunol; 2009 Jul; 183(1):277-84. PubMed ID: 19542439
[TBL] [Abstract][Full Text] [Related]
3. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
6. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
7. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells.
Kleijwegt FS; Laban S; Duinkerken G; Joosten AM; Zaldumbide A; Nikolic T; Roep BO
J Immunol; 2010 Aug; 185(3):1412-8. PubMed ID: 20574005
[TBL] [Abstract][Full Text] [Related]
8. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.
Boissonnas A; Scholer-Dahirel A; Simon-Blancal V; Pace L; Valet F; Kissenpfennig A; Sparwasser T; Malissen B; Fetler L; Amigorena S
Immunity; 2010 Feb; 32(2):266-78. PubMed ID: 20137985
[TBL] [Abstract][Full Text] [Related]
9. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
[TBL] [Abstract][Full Text] [Related]
10. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic alterations of dendritic cells are involved in suppressive activity of trichosanthin-induced CD8+CD28- regulatory T cells.
Wang B; Jiao Z; Shao X; Lu L; Yang N; Zhou X; Xin L; Zhou Y; Chou KY
J Immunol; 2010 Jul; 185(1):79-88. PubMed ID: 20498361
[TBL] [Abstract][Full Text] [Related]
12. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
13. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
[TBL] [Abstract][Full Text] [Related]
14. In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness.
Ahangarani RR; Janssens W; VanderElst L; Carlier V; VandenDriessche T; Chuah M; Weynand B; Vanoirbeek JA; Jacquemin M; Saint-Remy JM
J Immunol; 2009 Dec; 183(12):8232-43. PubMed ID: 20007587
[TBL] [Abstract][Full Text] [Related]
15. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection.
Martin S; Agarwal R; Murugaiyan G; Saha B
J Immunol; 2010 Jul; 185(1):551-9. PubMed ID: 20525887
[TBL] [Abstract][Full Text] [Related]
16. IL-15 and dendritic cells induce proliferation of CD4+CD25+ regulatory T cells from peripheral blood.
Xu S; Sun Z; Sun Y; Zhu J; Li X; Zhang X; Shan G; Wang Z; Liu H; Wu X
Immunol Lett; 2011 Oct; 140(1-2):59-67. PubMed ID: 21723324
[TBL] [Abstract][Full Text] [Related]
17. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
18. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
Tarbell KV; Yamazaki S; Steinman RM
Semin Immunol; 2006 Apr; 18(2):93-102. PubMed ID: 16469503
[TBL] [Abstract][Full Text] [Related]
19. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
20. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
